St-Pierre M V, Pang K S
Faculty of Pharmacy, University of Toronto, Canada.
J Pharmacol Exp Ther. 1993 Jun;265(3):1437-45.
Pharmacokinetic theory dictates that the extent of ensuing metabolism of a formed metabolite during drug transit through the liver is influenced by the number of consecutive reactions required for its genesis and the total intrinsic clearances of the precursors. This hypothesis was tested in the perfused murine liver by examining the successive conversion of the precursor diazepam (DZ) to its primary metabolite nordiazepam (NZ), and then the secondary metabolite oxazepam (OZ) and, finally, the tertiary metabolite, the oxazepam glucuronides. The concomitant C3-hydroxylation of DZ to temazepam, which can also be N-demethylated to form OZ, was minimal. The hepatic extraction ratios of NZ (E[NZ,DZ]) and OZ (E[OX,DZ]) after administration of [14C]DZ were compared to those obtained previously from [14C]NZ (E[NZ] and E[OZ,NZ]) and [3H]OZ (E[OZ]). The ability of three hepatic clearance models, the well-stirred, parallel-tube and dispersion models, to predict the experimental E[NZ,DZ] and E[OZ,DZ] was evaluated. DZ was highly extracted by the murine liver (E[DZ] = 0.95). The metabolism of NZ, generated in situ from DZ, was greater than that of preformed NZ (E[NZ,DZ] = 0.51; E[NZ] = 0.4), whereas E[OZ,DZ] (0.066) was similar to E[OZ,DZ] (0.056) and less than E[OZ] (0.0125). The unexpected observation of E[NZ,DZ] > E[NZ] may be explained by the coupling of N-demethylation and C3-hydroxylation/glucuronidation reactions or by a sequestration of hydrophobic substrates within the enzymic space, favoring sequential metabolism of products formed in situ. The atypical kinetic behavior of generated NZ may have also influenced the ensuing metabolic fate of its product, OZ, such that E[OZ,NZ] approximately E[OZ,DZ].(ABSTRACT TRUNCATED AT 250 WORDS)
药代动力学理论表明,药物在肝脏转运过程中形成的代谢产物后续代谢的程度,受其生成所需连续反应的数量以及前体的总内在清除率影响。通过研究前体地西泮(DZ)连续转化为其主要代谢产物去甲地西泮(NZ),然后是次要代谢产物奥沙西泮(OZ),最后是第三级代谢产物奥沙西泮葡糖醛酸苷,在灌注的小鼠肝脏中对这一假设进行了验证。DZ伴随的C3-羟基化生成替马西泮,其也可N-去甲基化形成OZ,但这种情况极少。将给予[14C]DZ后NZ(E[NZ,DZ])和OZ(E[OX,DZ])的肝脏提取率,与之前从[14C]NZ(E[NZ]和E[OZ,NZ])以及[3H]OZ(E[OZ])获得的提取率进行比较。评估了三种肝脏清除模型,即充分搅拌模型、平行管模型和弥散模型,预测实验性E[NZ,DZ]和E[OZ,DZ]的能力。DZ被小鼠肝脏高度提取(E[DZ] = 0.95)。由DZ原位生成的NZ的代谢,大于预先形成的NZ的代谢(E[NZ,DZ] = 0.51;E[NZ] = 0.4),而E[OZ,DZ](0.066)与E[OZ,DZ](0.056)相似且小于E[OZ](0.0125)。E[NZ,DZ] > E[NZ]这一意外观察结果,可能是由于N-去甲基化与C3-羟基化/葡糖醛酸化反应的偶联,或者是由于疏水底物在酶空间内的隔离,有利于原位形成产物的顺序代谢。生成的NZ的非典型动力学行为,可能也影响了其产物OZ的后续代谢命运,使得E[OZ,NZ]约等于E[OZ,DZ]。(摘要截短至250字)